Purchase Order 75N95020P00108
- Not listed
- This firm-fixed-price purchase order was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Bruker Biospin Corp. to provide annual service and maintenance for a Bruker Ascend 400 MHz nuclear magnetic resonance (NMR) spectrometer system with an Avance Neo Nanobay. The contract has a ceiling value of $68,484.50 and a period of performance through August 8, 2028. This award is not associated with any set-aside...
- This firm-fixed-price purchase order was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, to Bruker Biospin Corp, a for-profit manufacturer of scientific instruments and equipment. The $145,700.00 contract is for the provision of nuclear magnetic resonance (NMR) spectrometers, upgrades, maintenance, and related support services. The award has an ultimate completion date of May 31, 2019 and was not set aside for any...
- This federal contract award was made by the National Institute on Drug Abuse (NIDA), a civilian agency, to Bruker Biospin Corp, a for-profit manufacturer of scientific instruments. The $76,869.48 firm fixed-price purchase order is for the provision of nuclear magnetic resonance (NMR) spectrometers, upgrades, maintenance, and support services. The award does not have a set-aside designation. Bruker Biospin Corp has a history of providing specialized equipment and services to various U.S....
- This federal contract award was issued by the National Institute on Drug Abuse (NIDA), a civilian agency, to Bruker Biospin Corp, a for-profit manufacturer of scientific instruments and equipment. The $700,000.00 firm fixed-price purchase order was awarded on September 27, 2016 with a period of performance through June 30, 2017. The contract did not have a set-aside designation. Based on the vendor description, Bruker Biospin Corp has a history of providing nuclear magnetic resonance (NMR)...
- This is a $75,000.00 firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Bruker Biospin Corp, a subsidiary of Bruker Corporation. The contract is for the procurement of scientific instruments and equipment, specifically nuclear magnetic resonance (NMR) spectrometers, magnetic resonance imaging (MRI) systems, and electron spin resonance (EPR) spectrometers, along with...
- This is a firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Bruker Biospin Corp for maintenance services on a 4.7T Bruker Biospin nuclear magnetic resonance (NMR) scanner. The contract has a ceiling value of $98,615.95 and a period of performance from September 23, 2020 to September 23, 2023. The contract was awarded without full and open competition under the simplified acquisition...
- This is a firm-fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to Bruker Biospin Corp, a manufacturer of scientific instruments and provider of specialized equipment, maintenance, and support services. The contract, valued at $116,519.22, is for the provision of nuclear magnetic resonance spectrometers, upgrades, maintenance, and related services. Bruker Biospin Corp, a subsidiary of Bruker...
- This is a firm-fixed price purchase order awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse to Bruker Biospin Corp, a manufacturer of scientific instruments, on April 26, 2017. The contract, valued at $150,000.00, does not have a set-aside designation and is for the provision of nuclear magnetic resonance (NMR) spectrometers, upgrades, maintenance, and related support services. Bruker Biospin Corp is a manufacturer that provides specialized equipment and...
- The National Institute on Drug Abuse (NIDA) awarded a $1.35 million firm fixed-price purchase order to Bruker Biospin Corp on September 25, 2024, for a service contract renewal covering maintenance and support of multiple Bruker Magnetic Resonance Imaging (MRI) systems. The contract, with an ultimate completion date of September 24, 2029, will be performed at the contractor's location in Billerica, Massachusetts. Bruker Biospin Corp, a subsidiary of Bruker Scientific LLC and a specialized...
- This is a $33,636.72 firm-fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to Bruker Biospin Corp, a manufacturer of scientific instruments. The contract is for the delivery of specialized equipment, maintenance, and support services. Bruker Biospin Corp is a subsidiary of Bruker Scientific LLC, which has a history of providing analytical instrumentation and related support to various federal...
This is a $80,095.65 firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Bruker Biospin Corp for the renewal of yearly preventive-maintenance services for a nuclear magnetic resonance (NMR) spectrometer. This contract is not associated with any set-aside programs. Bruker Biospin Corp, a subsidiary of Bruker Corporation, is a manufacturer of scientific instruments that provides specialized equipment, maintenance, and support services to various federal government agencies. The company has an extensive history of delivering NMR spectrometers, equipment upgrades, and related services to agencies like the National Institutes of Health, Food and Drug Administration, and Department of Defense. This contract award reflects NIDA's continued reliance on Bruker's expertise in maintaining and servicing its NMR instrumentation to support the agency's research and analytical needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Other Administrative Action | $0 | 2/11/22 | |
| P00002 | Exercise an Option | $27.4k | 1/18/22 | |
| P00001 | Exercise an Option | $26.7k | 2/28/21 | |
| Not listed | Not listed | $26.0k | 2/25/20 |